Synvista Therapeutics, Inc. (SYNI)

Synvista Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2007	FY 2006	FY 2005	FY 2004	FY 2003
Period Ending	Dec 29, 2025	Dec 31, 2007	Dec 31, 2006	Dec 31, 2005	Dec 31, 2004	Dec 31, 2003
Market Capitalization	0	6	19	10	63	64
Market Cap Growth	-99.99%	-70.67%	85.81%	-83.56%	-0.05%	-2.80%
Enterprise Value	-	-12	17	2	49	52
Last Close Price	0.00	2.20	7.50	9.00	65.50	78.50
PS Ratio	0.00	111.43	312.52	104.39	418.25	-
PB Ratio	-	0.41	15.61	1.74	7.02	4.13
P/TBV Ratio	-	0.41	15.61	1.74	7.02	4.13
EV/Sales Ratio	-	-	275.33	22.56	325.22	-
Net Debt / Equity Ratio	-1.74	-1.13	-1.19	-1.10	-1.24	-1.08
Net Debt / EBITDA Ratio	0.72	1.58	0.23	0.50	0.77	1.15
Net Debt / FCF Ratio	0.85	1.97	0.20	0.47	0.85	1.04
Asset Turnover	0.00	0.01	0.01	0.01	0.01	-
Quick Ratio	1.91	5.52	1.39	5.77	4.31	8.92
Current Ratio	2.01	5.60	1.69	5.95	4.37	9.04
Return on Equity (ROE)	-102.91%	-213.00%	-488.76%	-167.76%	-114.27%	-97.36%
Return on Assets (ROA)	-50.59%	-65.18%	-85.93%	-88.54%	-62.84%	-52.95%
Return on Capital Employed (ROCE)	-240.90%	-71.50%	-522.10%	-222.00%	-160.60%	-97.30%
Earnings Yield	-660149533.33%	-282.83%	-91.14%	-120.84%	-21.98%	-22.75%
FCF Yield	-311353166.67%	-139.96%	-38.35%	-134.55%	-20.77%	-25.17%
Buyback Yield / Dilution	0.08%	-41.43%	-58.63%	-29.97%	-22.55%	-13.83%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.